Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1985-9-30
|
pubmed:abstractText |
The in-vitro activity (as measured by geometric mean MICs, mg/l) of Sch 34343 against aerobic and anaerobic bacteria was compared with that of 14 other selected beta-lactam antibiotics including aztreonam, latamoxef (moxalactam), ceftazidime and imipenem. Sch 34343 had good activity (less than 2 mg/l) against most Gram-negative aerobic bacteria whether or not they contained high levels of plasmid-mediated or chromosomally-mediated beta-lactamases. It was slightly less potent against strains of Morganella and Serratia (less than 4 mg/l) and inactive against Pseudomonas (greater than 64 mg/l). A very small inoculum effect was observed against strains containing beta-lactamases indicating stability. Unlike the third-generation cephalosporins, Sch 34343 had excellent activity (less than or equal to 0.18 mg/l) against staphylococci, comparable to that of imipenem and ampicillin. While Sch 34343 had equally good potency (0.17 mg/l) against penicillinase-positive staphylococci, it was inactive against methicillin-resistant staphylococci (greater than or equal to 35 mg/l). Sch 34343 also had good activity against streptococci. The most unusual aspect of the in-vitro activity was its activity against Bacteroides (including Bact. fragilis) and other anaerobes. Sch 34343 had mean MICs less than or equal to mg/l for all Bacteroides and Clostridium spp. tested except CI. difficile (3.4 mg/l).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Lactams,
http://linkedlifedata.com/resource/pubmed/chemical/Sch 34343,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Lactamases,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Lactams
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15 Suppl C
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-56
|
pubmed:dateRevised |
2004-11-18
|
pubmed:meshHeading |
pubmed-meshheading:3875604-Anti-Bacterial Agents,
pubmed-meshheading:3875604-Bacteria,
pubmed-meshheading:3875604-Bacteria, Aerobic,
pubmed-meshheading:3875604-Bacteria, Anaerobic,
pubmed-meshheading:3875604-Blood Proteins,
pubmed-meshheading:3875604-Gram-Negative Bacteria,
pubmed-meshheading:3875604-Gram-Positive Bacteria,
pubmed-meshheading:3875604-Haemophilus,
pubmed-meshheading:3875604-Lactams,
pubmed-meshheading:3875604-Microbial Sensitivity Tests,
pubmed-meshheading:3875604-Neisseria,
pubmed-meshheading:3875604-Protein Binding,
pubmed-meshheading:3875604-Streptococcus,
pubmed-meshheading:3875604-beta-Lactamases,
pubmed-meshheading:3875604-beta-Lactams
|
pubmed:year |
1985
|
pubmed:articleTitle |
Evaluation of the in-vitro antibacterial activity of Sch 34343.
|
pubmed:publicationType |
Journal Article
|